174 related articles for article (PubMed ID: 25041580)
1. Safety of intrathecal administration of cytosine arabinoside and methotrexate in dogs and cats.
Genoni S; Palus V; Eminaga S; Cherubini GB
Vet Comp Oncol; 2016 Sep; 14(3):331-6. PubMed ID: 25041580
[TBL] [Abstract][Full Text] [Related]
2. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
[No Abstract] [Full Text] [Related]
3. Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia.
Ozön A; Topaloğlu H; Cila A; Günay M; Cetin M
Brain Dev; 1994; 16(3):246-8. PubMed ID: 7943613
[TBL] [Abstract][Full Text] [Related]
4. Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia.
Eden OB; Goldie W; Wood T; Etcubanas E
Cancer; 1978 Jul; 42(1):53-8. PubMed ID: 276417
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of primary cerebral lymphoma].
Delwail V; Bataille B
Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
[TBL] [Abstract][Full Text] [Related]
6. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.
Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A
J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951
[TBL] [Abstract][Full Text] [Related]
7. Treatment of meningeal neoplasms.
Shapiro WR; Posner JB; Ushio Y; Chemik NL; Young DF
Cancer Treat Rep; 1977 Jul; 61(4):733-43. PubMed ID: 577896
[No Abstract] [Full Text] [Related]
8. Acute reversible neurological deficit following intrathecal chemotherapy.
Dunkelman H; Earl HM; Twelves C
Cancer Chemother Pharmacol; 1991; 27(4):329-30. PubMed ID: 1998991
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation, diagnostic findings and outcome in dogs diagnosed withpresumptive spinal-only meningoen-cephalomyelitis of unknown origin.
Cornelis I; Volk HA; Van Ham L; De Decker S
J Small Anim Pract; 2017 Mar; 58(3):174-182. PubMed ID: 28267222
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
Cole BF; Glantz MJ; Jaeckle KA; Chamberlain MC; Mackowiak JI
Cancer; 2003 Jun; 97(12):3053-60. PubMed ID: 12784341
[TBL] [Abstract][Full Text] [Related]
11. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.
Rubinstein LJ; Herman MM; Long TF; Wilbur JR
Cancer; 1975 Feb; 35(2):291-305. PubMed ID: 1053934
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.
Kim DY; Lee KW; Yun T; Park SR; Jung JY; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2003 Dec; 33(12):608-12. PubMed ID: 14769837
[TBL] [Abstract][Full Text] [Related]
13. Combination of Bleomycin and Cytosine Arabinoside Chemotherapy for Relapsed Canine Lymphoma.
Batschinski K; Dervisis N; Kitchell B; Newman R; Erfourth T
J Am Anim Hosp Assoc; 2018; 54(3):150-155. PubMed ID: 29558212
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of patients with meningeal carcinomatosis.
Nakagawa H; Murasawa A; Kubo S; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 May; 13(1):81-9. PubMed ID: 1613540
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
Kwong YL; Yeung DY; Chan JC
Ann Hematol; 2009 Mar; 88(3):193-201. PubMed ID: 19050889
[TBL] [Abstract][Full Text] [Related]
16. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside.
Menaut P; Landart J; Behr S; Lanore D; Trumel C
Vet Rec; 2008 Feb; 162(8):241-5. PubMed ID: 18296666
[TBL] [Abstract][Full Text] [Related]
17. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
[TBL] [Abstract][Full Text] [Related]
18. Treatment of central nervous system leukemia with intrathecal cytosine arabinoside.
Band PR; Holland JF; Bernard J; Weil M; Walker M; Rall D
Cancer; 1973 Oct; 32(4):744-8. PubMed ID: 4201653
[No Abstract] [Full Text] [Related]
19. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
20. Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
Bleyer A; Choi M; Wang SJ; Fuller CD; Raney RB
Pediatr Blood Cancer; 2009 Dec; 53(7):1205-10. PubMed ID: 19821538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
